Demand for Allergen-free Food in EU

Demand for Allergen-free Food in EU Size, Market Forecast and Outlook By FMI

The demand for allergen-free food in eu was valued at USD 4.17 billion in 2025, projected to reach USD 11.37 billion in 2026, and is forecast to expand to USD 22.37 billion by 2036 at a 7.0% CAGR. The absolute dollar expansion over the forecast period reflects both penetration growth among diagnosed allergic consumers and adoption by the larger lifestyle-driven consumer base. Organic nature leads at 60% share, reflecting the strong overlap between allergen-free purchasing and organic/clean-label consumer preferences. Beverages lead the product type at 38% share, driven by dairy-free milk alternatives, nut-free smoothies, and gluten-free beer categories. The everyday/lifestyle segment dominates application at 70% share, confirming that lifestyle purchasing now exceeds clinical-necessity purchasing as the primary demand driver.

As per FMI, the EU allergen-free food market operates under the comprehensive allergen labelling framework of EU Regulation 1169/2011, which mandates declaration of 14 major allergens on all pre-packed food products. This mandatory labelling creates both a compliance cost for manufacturers and a navigation tool for allergic consumers, establishing the regulatory infrastructure that enables the allergen-free market to function. Cross-contamination management through allergen-free production lines adds 15% to 30% to manufacturing costs, which translates into retail price premiums that the lifestyle consumer segment has demonstrated willingness to absorb.

All major EU markets reflect differentiated growth. Netherlands at 8.0%, Rest of Europe at 7.7%, Spain at 7.6%, Italy at 7.3%, France at 6.8%, Germany at 6.6%. Netherlands sets the pace, while Germany registers steadier growth.

Summary of Demand for Allergen-free Food in EU

• Demand for Allergen-free Food in EU Definition
  • Allergen-free food in the EU encompasses food and beverage products formulated to exclude one or more of the 14 allergens designated under EU Regulation 1169/2011, manufactured on dedicated or segregated production lines to minimize cross-contamination risk. The category includes gluten-free, dairy-free, nut-free, egg-free, soy-free, and multi-allergen-free products across beverages, confectionery, processed meat, bakery, snacks, and ready meal categories.
• Demand Drivers in the Market
  • Lifestyle-driven allergen avoidance expansion: Consumers without diagnosed food allergies are purchasing allergen-free products as part of dietary simplification, clean-label, and wellness-oriented purchasing patterns.
  • EU allergen labelling regulatory framework: Regulation (EU) 1169/2011 mandatory allergen declaration creates a consumer navigation infrastructure that enables allergen-free product discovery and comparison.
  • Infant and toddler allergen-free nutrition growth: EU paediatric allergy diagnosis rates are rising, driven by improved diagnostic protocols and increased parental awareness.
• Key Segments Analyzed in the FMI Report
  • Everyday/Lifestyle: 70.0% share in 2026 by Application.
  • Organic: 60.0% share in 2026 by Nature.
  • Netherlands: 8.0% compound growth, the fastest among tracked EU markets.
• Analyst Opinion at FMI
  • Nandini Roy Choudhury, Principal Consultant for Food & Beverage analysts observe that the EU allergen-free food market is a lifestyle conversion story where the addressable market has expanded from the 2% to 4% of the population with diagnosed food allergies to the 15% to 25% who actively avoid one or more allergens by choice. This lifestyle expansion is the primary growth engine, and it creates a category dynamic where product quality expectations are set by non-allergic consumers who will not tolerate taste compromise. Brands that deliver taste parity with conventional equivalents while maintaining allergen-free certification capture both the clinical and lifestyle segments. The manufacturing cost premium for dedicated allergen-free production lines is the barrier to entry that protects margins for committed producers against conventional manufacturers attempting to line-extend into allergen-free claims.
• Strategic Implications / Executive Takeaways
  • Procurement directors must secure diversified supply agreements to mitigate origin-concentration risk and seasonal availability gaps.
  • Product development teams should evaluate format premiumization opportunities where processing and certification capture value above commodity pricing.
  • Regulatory affairs teams must map EU compliance pathways as classification, labelling, and certification requirements vary by product application and member state.

Demand for Allergen-free Food in EU Key Takeaways

Metric	Details
Industry Size (2026)	USD 11.37 billion
Industry Value (2036)	USD 22.37 billion
CAGR (2026 to 2036)	7.0%

Source: Future Market Insights, 2026

Demand for Allergen-free Food in EU Definition

Allergen-free food in the EU encompasses food and beverage products formulated to exclude one or more of the 14 allergens designated under EU Regulation 1169/2011, manufactured on dedicated or segregated production lines to minimize cross-contamination risk. The category includes gluten-free, dairy-free, nut-free, egg-free, soy-free, and multi-allergen-free products across beverages, confectionery, processed meat, bakery, snacks, and ready meal categories.

Demand for Allergen-free Food in EU Inclusions

The report covers EU regional market sizes for allergen-free food from 2026 to 2036. Segment analysis includes nature (organic, conventional), product type (beverages, chocolate, processed meat and poultry, others), application (everyday/lifestyle, clinical/medical nutrition, infant and toddler, foodservice), and distribution channel (supermarkets/hypermarkets, online/e-commerce, specialty/health stores, pharmacy/healthcare). Country coverage includes Netherlands, Spain, Italy, France, Germany, and rest of Europe.

Demand for Allergen-free Food in EU Exclusions

The scope excludes naturally allergen-free whole foods (fresh fruits, vegetables, unprocessed meats) not marketed under allergen-free claims. Medical foods and enteral nutrition products regulated as medical devices are excluded. Allergen testing kits and laboratory services fall outside the analytical boundary.

Demand for Allergen-free Food in EU Research Methodology

• Primary Research: Structured interviews with procurement directors, formulation engineers, and channel managers mapping decision triggers and supplier qualification.
• Desk Research: Aggregated EU regulatory filings, trade publications, company reports, and Eurostat trade data for market sizing.
• Market-Sizing and Forecasting: Bottom-up aggregation of production, import/export flows, and end-use consumption with country-level pricing adjustments.
• Data Validation: Cross-validated against company financial disclosures and quarterly EU trade statistics.

Why is the Demand for Allergen-Free Food in EU Growing?

Industry expansion is being supported by the rapid evolution in food allergy prevalence across European populations and the corresponding demand for safe, nutritious alternatives that enable normal dietary patterns without health risks. Modern healthcare systems increasingly diagnose food allergies and intolerances through improved testing protocols, driving demand for products that address medical needs while delivering culinary satisfaction. The convergence of necessity-driven consumption from diagnosed individuals and choice-driven adoption from health-conscious consumers creates unprecedented market opportunities.

The growing body of scientific research demonstrating the connection between gut health, inflammation, and chronic diseases is driving demand for allergen-free products from manufacturers with appropriate safety certifications and nutritional credentials. Regulatory authorities across Europe are strengthening allergen labeling requirements and cross-contamination controls, creating competitive advantages for dedicated free-from producers. Clinical studies are providing evidence supporting allergen avoidance benefits beyond immediate reactions, including improved digestive health, reduced inflammation, and enhanced nutrient absorption, requiring specialized formulations that address nutritional gaps common in restricted diets while maintaining palatability and convenience.

Segmental Analysis

Sales are segmented by nature, product type, application, distribution channel, and country. By nature, demand is divided into organic and conventional categories. Based on product type, sales are categorized into beverages, chocolate, processed meat & poultry, and others. In terms of application, demand is segmented into everyday/lifestyle, clinical/medical nutrition, infant & toddler, and foodservice. By distribution channel, sales are classified into supermarkets/hypermarkets, online/e-commerce, specialty/health stores, and pharmacy/healthcare. Regionally, demand is focused on Germany, France, Italy, Spain, the Netherlands, and the Rest of Europe.

By Nature, Organic Segment Accounts for 60.0% Share

The organic segment is projected to account for 60.0% of EU allergen-free food sales in 2026, increasing to 65.0% by 2036, establishing itself as the dominant category reflecting consumer preference for clean, natural products. This commanding position is fundamentally supported by consumer perception linking organic production with enhanced safety and quality, growing availability of organic allergen-free ingredients, and willingness to pay premiums for products perceived as healthier and more sustainable. The segment delivers comprehensive value propositions, providing consumers with allergen-free products that also meet broader wellness criteria including pesticide avoidance, GMO-free status, and environmental sustainability.

This segment benefits from extensive retail support, premium positioning strategies, and consumer trust that builds loyalty in safety-critical categories. Additionally, organic certification offers advantages in product differentiation, margin enhancement, and alignment with European sustainability priorities, supported by robust supply chains ensuring consistent availability of certified ingredients.

The segment's share increase through 2036 reflects accelerating consumer prioritization of health and sustainability, with organic allergen-free products increasingly viewed as optimal choices for families managing dietary restrictions while maintaining wellness commitments throughout the forecast period.

By Product Type, Beverages Account for 38.0% Share

Beverages are positioned to represent 38.0% of total allergen-free food demand across European operations in 2026, increasing to 41.0% by 2036, reflecting the segment's accessibility and innovation potential. This considerable share directly demonstrates that plant-based milks, allergen-free juices, and functional beverages represent core categories where free-from alternatives achieve mainstream adoption beyond necessity-driven consumption.

Modern manufacturers increasingly optimize beverage formulations for nutrition and taste, driving demand for products featuring protein fortification, vitamin enhancement, and flavor innovations matching dairy and conventional alternatives. The segment benefits from continuous innovation focused on novel ingredients like oat, pea, and hemp, convenient formats supporting on-the-go consumption, and functional benefits addressing specific health concerns common in allergen-sensitive populations.

The segment's share growth through 2036 reflects expanding innovation and consumer acceptance, with beverages serving as gateway products introducing consumers to broader allergen-free categories while delivering convenience and nutritional benefits.

By Application, Everyday/Lifestyle Maintains 70.0% Share

Everyday/lifestyle application is strategically estimated to control 70.0% of total European allergen-free food sales in 2026, declining to 66.0% by 2036, reflecting the segment's importance for mainstream market development beyond medical necessity. European consumers increasingly adopt allergen-free products for perceived health benefits, weight management, and digestive wellness, creating volume opportunities transcending diagnosed populations.

The segment provides essential market scale through wellness-oriented consumers choosing free-from options, flexitarian households reducing allergen exposure, and families simplifying meal planning with universally safe products. Major European retailers systematically expand everyday allergen-free selections, often integrating products throughout stores rather than segregating in specialty sections, normalizing category presence.

The segment's declining share through 2036 reflects specialized segment growth, with clinical nutrition increasing from 12.0% to 14.0% and infant nutrition from 10.0% to 12.0%, as medical applications become more sophisticated and early allergen management gains importance.

By Distribution Channel, Supermarkets/Hypermarkets Lead at 52.0% Share

Supermarkets/hypermarkets are strategically positioned to contribute 52.0% of total European allergen-free food sales in 2026, declining to 45.0% by 2036, representing mainstream retail's critical role in category accessibility while facing digital disruption. These channels successfully deliver one-stop shopping convenience essential for time-pressed families, competitive pricing through scale economies, and product discovery through prominent merchandising.

Traditional retail serves mainstream consumers through dedicated free-from sections facilitating product discovery, integrated placement normalizing category presence, and promotional activities driving trial. Major European chains including Carrefour, Tesco, Lidl, and Albert Heijn systematically expand allergen-free ranges, often developing private label lines delivering value while maintaining safety standards.

The segment's declining share through 2036 reflects e-commerce expansion, which grows from 22.0% in 2026 to 30.0% in 2036, as digital natives increasingly value online shopping's product variety, subscription convenience, and detailed ingredient information supporting informed choices.

What are the Drivers, Restraints, and Key Trends?

EU allergen-free food sales are advancing rapidly due to increasing allergy prevalence requiring dietary management, growing health consciousness driving preventive consumption, and rising product quality achieving taste parity with conventional foods. The industry faces challenges, including premium pricing limiting mainstream adoption, cross-contamination risks affecting consumer confidence, and formulation complexity achieving functional performance without allergens. Continued innovation in ingredient technology and manufacturing processes remains central to industry development.

Advancement of Precision Fermentation Technologies

The rapidly accelerating development of precision fermentation and cellular agriculture technologies is fundamentally transforming allergen-free food from compromise products to superior alternatives, enabling authentic replication previously unattainable through traditional substitution. Advanced fermentation platforms featuring dairy protein production without cows, egg proteins without chickens, and novel ingredients with enhanced functionality allow companies to create products delivering genuine sensory experiences while eliminating allergen risks. These technological innovations prove particularly transformative for categories like cheese, yogurt, and baked goods where allergen-free versions historically suffered quality compromises.

Major food technology companies invest heavily in fermentation facilities, strain development, and scale-up capabilities, recognizing that precision biology represents breakthrough solutions for allergen-free challenges. Companies collaborate with biotechnology firms, research institutions, and regulatory bodies to develop commercially viable production systems that balance innovation benefits with safety validation and consumer acceptance supporting sustainable business models.

Integration of Gut Health Positioning

Modern allergen-free producers systematically incorporate digestive wellness messaging, microbiome support claims, and anti-inflammatory positioning, recognizing that gut health represents primary purchase motivation beyond allergen avoidance. Strategic integration of functional ingredients enables manufacturers to address digestive concerns through products featuring prebiotics, probiotics, and fermented ingredients where allergen-free formulations provide additional wellness benefits. These gut health formulations prove essential for market expansion, as consumers increasingly understand connections between digestive health, immune function.

Companies implement extensive research programs investigating ingredient-microbiome interactions, clinical trials validating digestive benefits, and consumer education explaining gut health importance. Manufacturers leverage wellness positioning in marketing communications, highlighting digestive comfort, immune support, and inflammation reduction, positioning allergen-free products as proactive health choices beyond reactive allergen management.

Growing Emphasis on Nutritional Completeness

European consumers increasingly demand nutritional equivalence or superiority in allergen-free products, driving manufacturers toward comprehensive fortification strategies and bioavailability optimization that addresses common deficiencies in restricted diets. This nutritional trend enables companies to build credibility through scientific substantiation, command premium pricing through added value, and differentiate products in competitive markets where nutrition influences purchase decisions. Nutritional optimization proves particularly important for children's products where growth and development requirements cannot be compromised.

The development of novel protein sources, vitamin/mineral premixes, and absorption enhancers expands manufacturers' abilities to meet nutritional demands while maintaining clean labels. Brands collaborate with nutritionists, pediatricians, and research institutions to develop evidence-based formulations balancing nutritional goals with taste acceptance, supporting premium positioning while meeting regulatory requirements and parental expectations.

Demand Analysis by Key Countries

Country	CAGR % (2026-2036)
Netherlands	8.0%
Rest of Europe	7.7%
Spain	7.6%
Italy	7.3%
France	6.8%
Germany	6.6%

EU allergen-free food sales demonstrate differentiated growth trajectories across major European economies, with smaller innovative markets and emerging regions outpacing established ones through 2036, driven by varying allergy prevalence, health consciousness levels, and market maturity stages. Netherlands shows exceptional growth from USD 518.0 million in 2026 to USD 1,119.2 million by 2036 at 8.0% CAGR. Rest of Europe expands from USD 1,110.0 million to USD 2,844.4 million at 7.7% CAGR. Spain grows robustly from USD 1,036.0 million to USD 2,019.8 million at 7.6% CAGR. Italy demonstrates USD 1,332.0 million to USD 2,526.9 million at 7.3% CAGR. France records USD 2,708.4 million to USD 5,122.5 million at 6.8% CAGR. Germany maintains steady expansion from USD 3,922.0 million to USD 7,353.7 million at 6.6% CAGR. The sales show varied regional development reflecting different healthcare systems, dietary cultures, and wellness adoption patterns across European countries.

Germany Maintains Leadership with Market Maturity

The demand for allergen-free food in Germany is projected to exhibit steady growth with a CAGR of 6.6% through 2036, driven by exceptionally well-developed health food infrastructure, comprehensive retail distribution, and established consumer awareness throughout the country. Germany's sophisticated free-from market and internationally recognized quality standards create substantial demand for innovative allergen-free products across all categories.

Major German retailers including Edeka, Rewe, DM, and Alnatura systematically expand allergen-free offerings, often featuring extensive dedicated sections with hundreds of SKUs across categories. German demand benefits from high health insurance coverage often supporting medical nutrition, substantial organic market overlap, and cultural acceptance of functional foods. The strong domestic manufacturing base, including specialized free-from producers, drives innovation and competitive pricing.

The relatively moderate growth rate reflects Germany's mature market status where established consumption patterns leave room for steady expansion through premiumization and innovation rather than explosive volume growth throughout the forecast period.

Growth drivers:

• Mature infrastructure supporting distribution
• Health consciousness driving adoption
• Manufacturing excellence ensuring quality

France Shows Strong Growth with Culinary Innovation

The demand for allergen-free food in in France is expanding at a CAGR of 6.8%, supported by sophisticated culinary culture embracing free-from innovations, strong pharmaceutical distribution channels, and increasing diagnosis rates driving medical necessity. France's renowned gastronomy creates unique challenges and opportunities for allergen-free products meeting taste expectations.

Major French retailers including Carrefour, Leclerc, and Monoprix actively promote allergen-free products through dedicated sections, private label development, and integration with conventional categories. French sales particularly benefit from strong bakery traditions driving gluten-free innovation, extensive pharmacy network providing medical nutrition, and government support for childhood allergy management. The country's emphasis on taste and quality creates opportunities for premium allergen-free products delivering authentic culinary experiences.

Success factors:

• Culinary standards driving quality
• Pharmacy distribution ensuring accessibility
• Childhood programs supporting awareness

Italy Demonstrates Strong Growth with Celiac Leadership

The demand for allergen-free food in Italy is growing at a CAGR of 7.3%, fundamentally driven by exceptional celiac disease prevalence, government reimbursement programs, and sophisticated gluten-free market development. Italy's unique position with mandatory celiac screening and financial support creates favorable conditions for broader allergen-free market expansion.

Major Italian retailers including Coop, Esselunga, and Conad actively promote allergen-free products through extensive gluten-free sections, often featuring hundreds of products including fresh items. Italian sales particularly benefit from government vouchers for celiac patients, restaurant requirements for gluten-free options, and cultural emphasis on dietary accommodation. The country's pasta and bakery expertise translates into superior gluten-free products achieving quality leadership.

Development factors:

• Celiac programs driving infrastructure
• Culinary expertise ensuring quality
• Government support enabling access

Spain Shows Robust Expansion with Rising Awareness

Demand for allergen-free food in Spain is projected to grow at an impressive CAGR of 7.6%, substantially supported by increasing allergy diagnosis rates, expanding retail modernization, and growing health consciousness among Spanish consumers. Spanish market transformation and improving economic conditions position allergen-free products as accessible health solutions aligned with Mediterranean dietary values.

Major Spanish retailers including Mercadona, Carrefour, and El Corte Inglés systematically introduce allergen-free ranges with competitive pricing and Spanish-specific products addressing local preferences. Spain's growing awareness of lactose intolerance and celiac disease drives specific category development. The country's expanding tourism sector increasingly demands allergen-free options, supporting foodservice market growth and retail expansion.

Growth enablers:

• Diagnosis improvements driving demand
• Retail modernization improving access
• Tourism requirements supporting foodservice

Netherlands Leads Growth Through Innovation Excellence

Demand for allergen-free food in the Netherlands is expanding at a leading CAGR of 8.0%, fundamentally driven by exceptional food technology capabilities, progressive health attitudes, and sophisticated understanding of nutrition among Dutch consumers. Dutch society demonstrates particular strength in innovation ecosystems, sustainable food initiatives, and early adoption positioning the Netherlands as European leader in allergen-free innovation.

Netherlands sales significantly benefit from concentrated food technology sector driving product innovation, high English proficiency enabling global knowledge transfer, and consumer openness to novel foods supporting market experimentation. Dutch retailers' efficiency and innovation culture creates favorable environment for allergen-free category development. The country's export orientation positions Dutch companies as European suppliers for innovative allergen-free products.

Innovation drivers:

• Technology ecosystem enabling development
• Progressive attitudes supporting adoption
• Export capabilities scaling innovations

Rest of Europe Shows Emerging Potential

Revenue from allergen-free food in Rest of Europe is expanding at 7.7% CAGR, representing diverse markets including Belgium, Austria, Poland, Scandinavian countries, and Eastern European nations experiencing varied market development stages. These markets collectively demonstrate growing potential as awareness increases, retail infrastructure develops, and diagnosis rates improve across previously underserved populations.

Nordic countries particularly show strong adoption driven by health consciousness and developed retail infrastructure, while Eastern European markets represent growth opportunities as economic development enables premium product purchases and healthcare improvements drive diagnosis rates.

Europe Market Split by Country

EU allergen-free food sales are projected to grow from USD 10,626.4 million in 2026 to USD 20,965.6 million by 2036, registering a robust CAGR of 7.0% over the forecast period. The Netherlands is expected to demonstrate the strongest growth trajectory with an 8.0% CAGR, supported by innovation ecosystem, health-conscious population, and early adoption of food technologies. Spain follows with 7.6% CAGR, attributed to rising allergy awareness and expanding retail infrastructure.

Germany maintains the largest share at 36.9% in 2026, driven by extensive health food infrastructure and established free-from market, while growing at 6.6% CAGR. Italy demonstrates 7.3% CAGR, reflecting dietary tradition adaptations and premium positioning opportunities.

Competitive Landscape

EU allergen-free food sales are defined by competition among specialized free-from brands, multinational food companies, and emerging startups focusing on specific allergen categories. Companies are investing in dedicated facilities, advanced formulations, clinical validation, and consumer education to deliver safe, nutritious, and delicious allergen-free products. Strategic partnerships with healthcare providers, patient organizations, and retailers emphasizing safety and quality are central to strengthening competitive position.

Major participants include Danone S.A. with an estimated 12.0% share, leveraging its plant-based leadership, extensive distribution, and innovation capabilities across dairy-free categories. Danone benefits from acquired brands like Alpro, comprehensive portfolio spanning beverages to yogurts, and established relationships with European retailers supporting category development.

Nestlé S.A. holds approximately 10.0% share through its broad portfolio approach, global R&D capabilities, and multi-category presence. The company's success across nutrition segments and ability to provide complete allergen-free solutions creates strong positioning among families managing multiple restrictions.

Unilever PLC accounts for roughly 7.0% share through its plant-based brand acquisitions, ice cream alternatives, and spreads portfolio. The company benefits from marketing excellence, distribution strength, and sustainability positioning aligning with conscious consumers.

Other key players including Mondelēz International (4.0%), General Mills Inc. (3.5%), and The Hain Celestial Group (3.0%) collectively with additional companies hold 60.5% share, reflecting the fragmented nature of European allergen-free market where numerous specialized brands serve specific allergen avoidance needs and product categories.

Key Players

• Danone S.A. 12%
• Nestlé S.A.
• Unilever PLC
• MondelÄ“z International
• General Mills Inc.
• The Hain Celestial Group
• Dr. Schär AG/SPA
• Enjoy Life Foods
• Hero Group
• Kellogg Company
• Mars Incorporated
• The Kraft Heinz Company
• Others

Scope of the Report

Metric	Value
Quantitative Units	USD 11.37 billion to USD 22.37 billion, CAGR 7.0%
Market Definition	Allergen-free food in the EU encompasses food and beverage products formulated to exclude one or more of the 14 allergens designated under EU Regulation 1169/2011, manufactured on dedicated or segregated production lines to minimize cross-contamination risk. The category includes gluten-free, dairy-free, nut-free, egg-free, soy-free, and multi-allergen-free products across beverages, confectionery, processed meat, bakery, snacks, and ready meal categories.
Segmentation	Nature (Organic, Conventional), Product Type (Beverages, Chocolate, Processed Meat & Poultry, Others), Application (Everyday/Lifestyle, Clinical/Medical Nutrition, Infant & Toddler, Foodservice), Distribution Channel (Supermarkets/Hypermarkets, Online/E-commerce, Specialty/Health Stores, Pharmacy/Healthcare)
Regions Covered	Europe (EU member states)
Countries Covered	Netherlands, Rest of Europe, Spain, Italy, France, Germany
Key Companies Profiled	Danone S.A. 12%, Nestlé S.A., Unilever PLC, Mondelēz International, General Mills Inc., The Hain Celestial Group, Dr. Schär AG/SPA, Enjoy Life Foods, Hero Group, Kellogg Company
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up methodology using EU production, import/export, and consumption data, cross-validated against company disclosures.

Key Segments

Nature

• Organic
• Conventional

Product Type

• Beverages
• Chocolate
• Processed Meat & Poultry
• Others

Application

• Everyday/Lifestyle
• Clinical/Medical Nutrition
• Infant & Toddler
• Foodservice

Distribution Channel

• Supermarkets/Hypermarkets 52
• Online/E-commerce
• Specialty/Health Stores
• Pharmacy/Healthcare

Countries

• Germany
• France
• Italy
• Spain
• Netherlands
• Rest of Europe

Bibliography

• 1. European Commission. (2024). Regulation (EU) No 1169/2011 on Food Information to Consumers: Allergen Labelling Provisions, Consolidated Version. EUR-Lex.
• 2. European Academy of Allergy and Clinical Immunology (EAACI). (2024). Food Allergy Prevalence in Europe: Systematic Review and Meta-Analysis Update. EAACI.
• 3. Dr. Schar AG/SPA. (2024). Annual Report 2024: Gluten-Free Division. Dr. Schar.
• 4. Food Standards Agency (FSA), United Kingdom. (2024). Precautionary Allergen Labelling: Technical Guidance for Food Businesses. FSA.
• 5. Euromonitor International. (2024). Passport Database: Free-From Foods in Western Europe. Euromonitor.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.